1,595 top medical experts on Noninfiltrating Intraductal Carcinoma across 49 countries and 41 U.S. states, including 1,553 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Noninfiltrating Intraductal Carcinoma: A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Adenocarcinoma (5,212), Breast Carcinoma In Situ (926), and Medullary Lobular Ductal Neoplasms (49).
  4. Clinical Trials ClinicalTrials.gov : at least 147 including 22 Active, 53 Completed, 33 Recruiting
  5. Synonyms: Intraductal Carcinoma,  DCIS,  Ductal Carcinoma In Situ




    Computing Expert Listing ...